BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37594219)

  • 21. Barriers to Price and Quality Transparency in Health Care Markets.
    Rao P; Fischer SH; Vaiana ME; Taylor EA
    Rand Health Q; 2022 Jun; 9(3):1. PubMed ID: 35837511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Association between Hospital-Physician Vertical Integration and Outpatient Physician Prices Paid by Commercial Insurers: New Evidence.
    Godwin J; Arnold DR; Fulton BD; Scheffler RM
    Inquiry; 2021; 58():46958021991276. PubMed ID: 33682524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insurers negotiate lower hospital prices for HIX than for commercial groups.
    Randall S; Duffy EL; Green S; Trish E
    Am J Manag Care; 2022 Sep; 28(9):e347-e350. PubMed ID: 36121367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Playing by the Rules? Tracking U.S. Hospitals' Responses to Federal Price Transparency Regulation.
    Nikpay S; Carroll C; Golberstein E; Abraham JM
    J Healthc Manag; 2024 Jan-Feb 01; 69(1):45-58. PubMed ID: 38175534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health insurance and the demand for medical care: Instrumental variable estimates using health insurer claims data.
    Dunn A
    J Health Econ; 2016 Jul; 48():74-88. PubMed ID: 27107371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How important is price variation between health insurers?
    Craig SV; Ericson KM; Starc A
    J Health Econ; 2021 May; 77():102423. PubMed ID: 33838593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increasing Divergence in Drug Prices Between the United States and Germany After Implementation of Comparative Effectiveness Analysis and Collective Price Negotiations.
    Berkemeier F; Whaley C; Robinson JC
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1310-1317. PubMed ID: 31778624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physician practice competition and prices paid by private insurers for office visits.
    Baker LC; Bundorf MK; Royalty AB; Levin Z
    JAMA; 2014 Oct 22-29; 312(16):1653-62. PubMed ID: 25335147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimating the Impact of New Health Price Transparency Policies.
    Parente ST
    Inquiry; 2023; 60():469580231155988. PubMed ID: 36803142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in Cancer Care Expenditures and Utilization for Surgery by Hospital Type Among Patients With Private Insurance.
    Takvorian SU; Yasaitis L; Liu M; Lee DJ; Werner RM; Bekelman JE
    JAMA Netw Open; 2021 Aug; 4(8):e2119764. PubMed ID: 34342648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uncovering the interhospital price variations for vasectomies in the United States.
    Mortach S; Sellke N; Rhodes S; Sun HH; Tay K; Abou Ghayda R; Loeb A; Thirumavalavan N
    Int J Impot Res; 2024 Feb; ():. PubMed ID: 38383856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do high-deductible health plans affect price paid for childbirth?
    Cliff BQ
    Health Serv Res; 2022 Feb; 57(1):27-36. PubMed ID: 34254295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insurer-Provider Networks in the Medical Care Market.
    Ho K
    Am Econ Rev; 2009 Mar; 99(1):393-430. PubMed ID: 29504738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large self-insured employers lack power to effectively negotiate hospital prices.
    Eisenberg MD; Meiselbach MK; Bai G; Sen AP; Anderson G
    Am J Manag Care; 2021 Jul; 27(7):290-296. PubMed ID: 34314118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Large Variations in the Prices of Urologic Procedures at Academic Medical Centers 1 Year After Implementation of the Price Transparency Final Rule.
    Gul ZG; Sharbaugh DR; Guercio CJ; Pelzman DL; Jones CA; Hacker EC; Anyaeche VI; Bowers L; Shah AM; Stencel MG; Yabes JG; Jacobs BL; Davies BJ
    JAMA Netw Open; 2023 Jan; 6(1):e2249581. PubMed ID: 36602800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Market structure and hospital-insurer bargaining in the Netherlands.
    Halbersma RS; Mikkers MC; Motchenkova E; Seinen I
    Eur J Health Econ; 2011 Dec; 12(6):589-603. PubMed ID: 20853127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hospital pricing: cost shifting and competition.
    Morrisey MA
    EBRI Issue Brief; 1993 May; (137):1-17. PubMed ID: 10129621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in Drug List Prices and Amounts Paid by Patients and Insurers.
    Yang EJ; Galan E; Thombley R; Lin A; Seo J; Tseng CW; Resneck JS; Bach PB; Dudley RA
    JAMA Netw Open; 2020 Dec; 3(12):e2028510. PubMed ID: 33295971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dropped out or pushed out? Insurance market exit and provider market power in Medicare Advantage.
    Pelech D
    J Health Econ; 2017 Jan; 51():98-112. PubMed ID: 28126701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variation in Cost of Echocardiography Within and Across United States Hospitals.
    Wei C; Milligan M; Lam M; Heidenreich PA; Sandhu A
    J Am Soc Echocardiogr; 2023 Jun; 36(6):569-577.e4. PubMed ID: 36638930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.